TP53 and ovarian carcinoma: A study on a cohort of patients with epithelial ovarian cancer identified 77.4% of patients having at least one somatic or germline mutation, and that the most frequent germline and somatic mutations were BRAC1/2 and TP53 mutations, respectively11.